UNSPSC 51373304: Acetaminophen/aspirin/codeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373304 Acetaminophen/aspirin/codeine is a Commodity code that in recent state and local procurement activity covers naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products supplied to community health facilities and state employee health plans. State and local buyers under this code include county health departments, state HHS commissions, and cooperative purchasing alliances that aggregate demand across multiple participating jurisdictions. The work ranges from direct procurement of emergency-response medications for public health initiatives to wholesale pharmaceutical supply agreements supporting statewide government employee benefit programs through authorized distributors.

Activity appears concentrated in the Southeast and Upper Midwest. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, all shipping included in bid pricing, and a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission posted an RFI (HHS0017013, response due April 3, 2026) exploring vendor capability for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) to participating state and local facilities including Oregon, with awards effective July 1, 2026 and evaluation weighted 75 percent on price competitiveness. Vendors must meet cGMP and Drug Supply Chain Security Act compliance, maintain wholesaler relationships with chargeback systems, and carry $5 million commercial general liability insurance.